Does febuxostat (Uloric) cause macrocytic anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Uloric (Febuxostat) Cause Macrocytic Anemia?

No, febuxostat (Uloric) does not cause macrocytic anemia based on available FDA labeling and clinical evidence.

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for Uloric does not list macrocytic anemia or any form of anemia as a known adverse effect 1. The documented adverse events associated with febuxostat include:

  • Gastrointestinal effects: Abdominal pain and diarrhea
  • Musculoskeletal pain
  • Rare but serious: Hypersensitivity reactions

Hematologic Concerns with Febuxostat

While macrocytic anemia is not associated with febuxostat, there are important hematologic safety considerations:

Agranulocytosis (Rare but Serious)

  • Febuxostat-induced neutropenia and agranulocytosis have been reported, though uncommon 2
  • This represents a serious, life-threatening complication requiring clinical vigilance
  • This is NOT macrocytic anemia but rather a white blood cell disorder

Myelosuppression via Drug Interactions

  • Febuxostat is contraindicated with azathioprine and mercaptopurine 1, 3
  • As a xanthine oxidase inhibitor, febuxostat increases plasma concentrations of these thiopurine drugs
  • This interaction can cause severe myelosuppression, including pancytopenia 3
  • Median time to event: 1.6 months after starting combination therapy
  • 16 of 19 reported cases required hospitalization; 15 required blood product transfusions 3

Understanding Macrocytic Anemia Causes

Macrocytic anemia results from entirely different mechanisms 4, 5:

  • Megaloblastic causes: Vitamin B12 deficiency, folate deficiency, impaired DNA synthesis
  • Nonmegaloblastic causes: Chronic liver disease, hypothyroidism, alcohol use disorder, myelodysplastic syndromes
  • Physiologic: Reticulocytosis in response to acute blood loss

None of these mechanisms are related to febuxostat's pharmacologic action as a xanthine oxidase inhibitor.

Clinical Bottom Line

If a patient on febuxostat develops macrocytic anemia, look for alternative causes rather than attributing it to the medication. The standard workup for macrocytic anemia (B12, folate, thyroid function, liver function, reticulocyte count) should proceed as it would for any patient, as febuxostat is not implicated in this condition.

Related Questions

In a patient with isolated macrocytic anemia affecting only the red blood cell line, what is the appropriate diagnostic work‑up and initial treatment?
In a 57-year-old male smoker with macrocytic anemia (MCV 127 fL), leukopenia (WBC 3.4 ×10⁹/L), hemoglobin 10.2 g/dL, hematocrit 28.9 %, platelets 159 ×10⁹/L, and normal thyroid function, what is the most likely diagnosis and what initial workup and management steps should be taken?
In an 86‑year‑old woman with macrocytic anemia (MCV 105.6 fL), low red blood cell count, normal hemoglobin, and hemoglobin A1c 6.4 %, what are the likely causes and what diagnostic work‑up and treatment should be pursued?
Please interpret the provided laboratory results, highlighting the macrocytic anemia and hypokalemia, and recommend appropriate diagnostic and therapeutic next steps.
What are the causes of macrocytic anemia?
What is the recommended protocol for transitioning a patient from quetiapine (Seroquel) 100 mg to lumateperone (Caplyta) 42 mg?
Are there any genetic conditions that predispose to ovarian torsion?
Does febuxostat effectively lower uric acid levels in patients with gout?
I have been taking lithium 900 mg daily for five days and now have clammy hands, nausea, and loss of appetite; what should I do?
In a 59-year-old female nursing-home resident with depression, anxiety, and a history of alcohol abuse who is taking bupropion XL (bupropion) 300 mg daily, escitalopram 20 mg daily, trazodone 100 mg at bedtime and 25 mg in the morning, amphetamine/dextroamphetamine (Adderall) 10 mg daily, and divalproex sodium (Depakote) 250 mg twice daily, and who now presents with worsening depression, social isolation, increased daytime sleepiness, and anhedonia, what is the optimal psychotropic treatment approach?
Can clindamycin cause esophageal ulceration?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.